NexGel Signs Deal for Regenerative Biomaterial Portfolio

NexGel has signed a definitive agreement to license and acquire a portfolio of commercial-stage regenerative biomaterial products. The deal is described as a “transformative portfolio” of regenerative biomaterial products.

The provided material does not include deal value, the identity of the seller, or the specific product list, but it does confirm the transaction structure combines licensing with an acquisition component.